Date Filed | Type | Description |
01/05/2023 |
4
| Robbins Jim B (SVP, Finance & Administration) has filed a Form 4 on VIVEVE MEDICAL, INC.
Txns:
| Granted 57,000 restricted stock units
@ $0 |
|
01/06/2022 |
4
| Robbins Jim B (SVP, Finance & Administration) has filed a Form 4 on VIVEVE MEDICAL, INC.
Txns:
| Granted 42,000 options to buy
@ $1.26, valued at
$52.9k
|
|
12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/27/2019 |
4
| Robbins Jim B (VP, Finance & Administration) has filed a Form 4 on VIVEVE MEDICAL, INC.
Txns:
| Granted 330,000 options to buy
@ $0.869, valued at
$286.8k
|
|
02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/16/2019 |
4
| Robbins Jim B (VP, Finance & Administration) has filed a Form 4 on VIVEVE MEDICAL, INC.
Txns:
| Granted 95,000 options to buy
@ $1.24, valued at
$117.8k
|
|
05/15/2018 |
4
| Robbins Jim B (VP, Finance & Administration) has filed a Form 4 on VIVEVE MEDICAL, INC.
Txns:
| Granted 32,500 options to buy
@ $1.97, valued at
$64k
|
|
01/25/2018 |
4
| Robbins Jim B (VP of Finance & Administration) has filed a Form 4 on VIVEVE MEDICAL, INC.
Txns:
| Granted 58,750 options to buy
@ $4.48, valued at
$263.2k
|
|
03/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/01/2009 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
11/17/2009 |
4
| Robbins Jim B (Vice President, Finance) has filed a Form 4 on MICRUS ENDOVASCULAR CORP
Txns:
| Sold 1,111 shares
@ $13.5, valued at
$15k
|
|
07/16/2009 |
4
| Robbins Jim B (Vice President, Finance) has filed a Form 4 on MICRUS ENDOVASCULAR CORP |
07/01/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
06/09/2009 |
4
| Robbins Jim B (Vice President, Finance) has filed a Form 4 on MICRUS ENDOVASCULAR CORP |